Raygene Martier

731 total citations
11 papers, 552 citations indexed

About

Raygene Martier is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Raygene Martier has authored 11 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 3 papers in Genetics. Recurrent topics in Raygene Martier's work include Genetic Neurodegenerative Diseases (4 papers), Virus-based gene therapy research (3 papers) and RNA Interference and Gene Delivery (3 papers). Raygene Martier is often cited by papers focused on Genetic Neurodegenerative Diseases (4 papers), Virus-based gene therapy research (3 papers) and RNA Interference and Gene Delivery (3 papers). Raygene Martier collaborates with scholars based in Netherlands, Switzerland and Germany. Raygene Martier's co-authors include Pavlina Konstantinova, S J van Deventer, Harald Petry, Jana Miniarikova, Melvin M. Evers, Jolanda M.P. Liefhebber, Ori Staszewski, Jeroen E. J. Guikema, Richard E. Baker and Cynthia Brouwers and has published in prestigious journals such as Molecular Cell, Frontiers in Neuroscience and Gene Therapy.

In The Last Decade

Raygene Martier

11 papers receiving 530 citations

Peers

Raygene Martier
Raygene Martier
Citations per year, relative to Raygene Martier Raygene Martier (= 1×) peers Lorea Blázquez

Countries citing papers authored by Raygene Martier

Since Specialization
Citations

This map shows the geographic impact of Raygene Martier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raygene Martier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raygene Martier more than expected).

Fields of papers citing papers by Raygene Martier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raygene Martier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raygene Martier. The network helps show where Raygene Martier may publish in the future.

Co-authorship network of co-authors of Raygene Martier

This figure shows the co-authorship network connecting the top 25 collaborators of Raygene Martier. A scholar is included among the top collaborators of Raygene Martier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raygene Martier. Raygene Martier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Martier, Raygene, Jolanda M.P. Liefhebber, Cynthia Brouwers, et al.. (2020). Transduction patterns in the CNS following various routes of AAV-5-mediated gene delivery. Gene Therapy. 28(7-8). 435–446. 26 indexed citations
2.
Martier, Raygene & Pavlina Konstantinova. (2020). Gene Therapy for Neurodegenerative Diseases: Slowing Down the Ticking Clock. Frontiers in Neuroscience. 14. 580179–580179. 50 indexed citations
3.
Martier, Raygene, Jolanda M.P. Liefhebber, Ana Garcı́a-Osta, et al.. (2019). Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy. Molecular Therapy — Nucleic Acids. 16. 26–37. 76 indexed citations
4.
Martier, Raygene, Jeannette Hübener‐Schmid, Jiřı́ Klı́ma, et al.. (2019). Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease. Molecular Therapy — Methods & Clinical Development. 15. 343–358. 35 indexed citations
5.
Martier, Raygene, Jolanda M.P. Liefhebber, Jana Miniarikova, et al.. (2019). Artificial MicroRNAs Targeting C9orf72 Can Reduce Accumulation of Intra-nuclear Transcripts in ALS and FTD Patients. Molecular Therapy — Nucleic Acids. 14. 593–608. 47 indexed citations
6.
Liefhebber, Jolanda M.P., Raygene Martier, Angelina Huseinovic, et al.. (2019). In-Depth Characterization of a Mifepristone-Regulated Expression System for AAV5-Mediated Gene Therapy in the Liver. Molecular Therapy — Methods & Clinical Development. 13. 512–525. 4 indexed citations
7.
Brouwers, Cynthia, Raygene Martier, Astrid Vallès, et al.. (2019). AAV5-miHTT Lowers Huntingtin mRNA and Protein without Off-Target Effects in Patient-Derived Neuronal Cultures and Astrocytes. Molecular Therapy — Methods & Clinical Development. 15. 275–284. 48 indexed citations
8.
Miniarikova, Jana, Raygene Martier, Cynthia Brouwers, et al.. (2017). AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington’s disease. Gene Therapy. 24(10). 630–639. 80 indexed citations
9.
Miniarikova, Jana, Ilaria Zanella, Angelina Huseinovic, et al.. (2016). Design, Characterization, and Lead Selection of Therapeutic miRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington's Disease. Molecular Therapy — Nucleic Acids. 5. e297–e297. 99 indexed citations
10.
Verheij, Joanne, Chris van der Loos, Gerrit K. Hooijer, et al.. (2013). Therapeutic expression of hairpins targeting apolipoprotein B100 induces phenotypic and transcriptome changes in murine liver. Gene Therapy. 21(1). 60–70. 10 indexed citations
11.
Staszewski, Ori, et al.. (2011). Activation-Induced Cytidine Deaminase Induces Reproducible DNA Breaks at Many Non-Ig Loci in Activated B Cells. Molecular Cell. 41(2). 232–242. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026